EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Critical Pitfalls in the Flow Cytometric Analysis of Mast Cells in Patients With Systemic Mastocytosis

Abdulrazzaq Alheraky iD, Kees Meijer, Marije T Nijk, Saskia K Klein, Hanneke N G Oude Elberink, Ido P Kema, André B Mulder

Cytometry Part A · 2025

DOI: 10.1002/cyto.a.24950 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytometry Part A, 2025. Verfasst von Abdulrazzaq Alheraky und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Mastocytosis, Systemic, Flow Cytometry, Mast Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic mastocytosis (SM) is a neoplastic disease characterized by abnormal mast cell (MC) activation and proliferation. Accurate diagnosis often relies on flow cytometry to detect aberrant CD25, CD2, and CD30 expression on MCs in bone marrow (BM). However, the frequently low abundance of MCs in BM, lack of completely specific antigens, and strong and highly variable autofluorescence can cause misinterpretation and lead to diagnostic misclassifications. We investigated the potentially interfering cell populations in flow cytometric analysis of MCs based on literature and expert insights, focusing on CD117, CD45, CD203c, and FcεR1. Additionally, we determined the most appropriate approach to quantify aberrant CD25, CD2, and CD30 expression. Apoptotic granulocytes frequently cause misinterpretation by mimicking strong CD117 and aberrant CD25, CD2, and CD30 expression, and must be distinguished from MCs with a viability dye like DRAQ7. CD117‐positive myeloblasts and promyelocytes overlap with CD117‐reduced immature MCs in advanced SM disease and can be differentiated using CD203c. Quantifying CD25, CD2, and CD30 expression is skewed on log‐transformed scales due to the strong and highly heterogeneous autofluorescence of MCs. Linear calculation of net expression levels of CD25, CD2, and CD30 yields the highest accuracies in predicting SM with a Youden index of 0.96, 0.93, and 0.88, respectively. Incorporating a viability dye like DRAQ7 and CD203c into the flow cytometric analysis for MC identification, along with the linear quantification of aberrant expression, significantly enhances the correct identification of MCs and increases the diagnostic accuracy of aberrant CD25, CD2, and CD30 expression for SM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mastocytosis, SystemicFlow CytometryMast CellsHumansProto-Oncogene Proteins c-kitCD2 AntigensInterleukin-2 Receptor alpha SubunitBone MarrowImmunophenotypingBone Marrow CellsKi-1 AntigenAntigens, CDFemaleMale

Stichwörter der Autor:innen

flow cytometrymast cellpitfallssystemic mastocytosis

Substanzen

Proto-Oncogene Proteins c-kitCD2 AntigensInterleukin-2 Receptor alpha SubunitKi-1 AntigenAntigens, CDKIT protein, human

Autor:innen und Institutionen

  • Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Department of Allergology, University of Groningen, Groningen, the Netherlands.
  • Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

ORCID-Profile: Abdulrazzaq Alheraky

Zitieren

APA

Alheraky, A., Meijer, K., Nijk, M. T., Klein, S. K., Oude Elberink, H. N. G., Kema, I. P., & Mulder, A. B. (2025). Critical Pitfalls in the Flow Cytometric Analysis of Mast Cells in Patients With Systemic Mastocytosis. Cytometry Part A. https://doi.org/10.1002/cyto.a.24950

Vancouver

Alheraky A, Meijer K, Nijk MT, Klein SK, Oude Elberink HNG, Kema IP, et al. Critical Pitfalls in the Flow Cytometric Analysis of Mast Cells in Patients With Systemic Mastocytosis. Cytometry Part A. 2025. doi:10.1002/cyto.a.24950

BibTeX
@article{Alheraky2025,
  author = {Alheraky, Abdulrazzaq and Meijer, Kees and Nijk, Marije T and Klein, Saskia K and Oude Elberink, Hanneke N G and Kema, Ido P and Mulder, André B},
  title = {Critical Pitfalls in the Flow Cytometric Analysis of Mast Cells in Patients With Systemic Mastocytosis},
  journal = {Cytometry Part A},
  year = {2025},
  doi = {10.1002/cyto.a.24950}
}
Kostenlos starten →